U.S. Patent 7826981 was awarded to DexCom, Inc. on 2010-11-02 and describes a “System and methods for processing analyte sensor data.” This patent has been cited 241 times by other U.S. patents which places it in the top 500 cited patents since 2010 according to our law firm research, and makes it of the most innovative medical technology patents in the field of instruments. The abstract states:

Systems and methods for processing sensor analyte data, including initiating calibration, updating calibration, evaluating clinical acceptability of reference and sensor analyte data, and evaluating the quality of sensor calibration. During initial calibration, the analyte sensor data is evaluated over a period of time to determine stability of the sensor. The sensor may be calibrated using a calibration set of one or more matched sensor and reference analyte data pairs. The calibration may be updated after evaluating the calibration set for best calibration based on inclusion criteria with newly received reference analyte data. Fail-safe mechanisms are provided based on clinical acceptability of reference and analyte data and quality of sensor calibration. Algorithms provide for optimized prospective and retrospective analysis of estimated blood analyte data from an analyte sensor. Link: U.S. Patent 7826981

This patent was originally filed on 2005-01-18 which gives it a processing time of 2114 days, compared to an average processing time of 1190 in the field. DexCom, Inc. has 423 total patents. The first named inventor is James H. Brauker of Addison, IL. The primary examiner was Michael P Nghiem.

Select Patents monitors top medical technology patents and instruments patents which have been allowed and granted worldwide. If you would like legal advice regarding a patent or would like to file a patent go to https://selectpatents.wpengine.com/contact/